产品名称Brodalumab (anti-IL17RA), 白细胞介素 17 受体 A 抗体 别名布罗达单抗 | 柏达鲁单抗 | 布达鲁单抗(抗IL17RA) 英文别名Recombinant Brodalumab Antibody | Brodalumab | AMG 827 | KHK4827 | Brodalumab (anti-IL17RA) | Anti-IL-17Ra / CD217 Reference Antibody (brodalumab) | CANDF5 antibody |...
aladdin 阿拉丁 Ab169276 Brodalumab (anti-IL17RA) 1174395-19-7 Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated ￥6169.90 VIP1年 上海阿拉丁生化科技股份有限公司 ...
英文别名 immunoglobulin G2-kappa,anti-[Homo sapiens IL17RA (interleukin 17 receptor A,CD217)],Homo sapiens monoclonal antibody;gamma2 heavy chain (1-442) [Homo sapiens VH (IGHV1-18*01(96.90%) -(IGHD)-IGHJ4*01) [8.8.9] (1-116) -Homo sapiens IGHG2*01 (117-442 CAS号 1174395-19...
Entrez Gene IDs 23765 (Human); 16172 (Mouse); 312679 (Rat); 486759 (Canine); 101925679 (Cynomolgus Monkey) Alternate Names CD217 antigen; CD217; Cdw217; CDw217interleukin 17 receptor; hIL-17R; IL-17 R; IL-17 RA; IL-17 receptor A; IL17RA; IL-17RA; IL-17RAMGC10262...
anti-IL17anti-IL17RAmonoclonal antibodiespsoriasisPsoriasis is now understood to also be under the driving influence of the IL-17/IL-23 axis, and the medical breakthrough of novel IL-17 inhibitor medications signals a paradigm shift in the way psoriatic patients are managed medically. Brodalumab, ...
中文同义词: 布罗达单抗;布罗利尤单抗 英文名称: Brodalumab 英文同义词: Brodalumab;Research Grade Brodalumab(DHJ38901);Brodalumab (anti-IL17RA);LP 0160|||KHK-4827|||AMG-827 CAS号: 1174395-19-7 分子式: 分子量: 0 EINECS号: 信息错误报告 您的Email: 按国家浏览Brodalumab国外供应商 中国供应商美...
Objective To investigate the efficacy and safety of brodalumab, a fully human anti-interleukin-17 receptor A monoclonal antibody, in patients with axial spondyloarthritis (axSpA). Methods In a multicentre, placebo-controlled phase 3 study ( NCT02985983 ) conducted at 48 sites across Japan, Korea ...
doi:10.1136/ANNRHEUMDIS-2021-220759Yan ZhaoJin-Xian HuangBMJ Publishing Group Ltd
anti-IL17RAPASI 100Introduction: Psoriasis is now understood to also be under the driving influence of the IL-17/IL-23 axis, and the medical breakthrough of novel IL-17 inhibitor medications signals a paradigm shift in the way psoriatic patients are managed medically.Galluzzo, M.Talamonti, M....